Neutral impactIPO

Kotak Mutual Fund launches Kotak Nifty Pharma Index Fund

MillenniumPost 58 min ago·19 Nov 2026, 5:49 pm

Kotak Mahindra Asset Management Company has launched a new exchange-traded fund (ETF) called the Kotak Nifty Pharma Index Fund. This fund aims to track the performance of the Nifty Pharma Index, which includes the top pharmaceutical companies listed on the National Stock Exchange. By investing in this fund, investors gain exposure to a basket of leading drugmakers, allowing them to participate in the sector's growth without having to pick individual stocks.

For investors, this launch offers a convenient way to diversify their portfolio within the healthcare sector. The fund's performance will closely mirror the underlying index, making it a passive investment option. It is particularly relevant for those looking to hedge against market volatility or gain systematic exposure to India's growing pharmaceutical industry.

Investors should monitor the fund's expense ratio and the performance of the underlying pharma stocks. Tracking errors and liquidity levels in the ETF will also be key factors to watch. This fund provides a sector-specific investment avenue, but as with any investment, it is important to review the fund's objectives and risks before committing capital.

Key takeaways

  • Category: IPO.

Why it matters

A routine update. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at MillenniumPost.

More IPO news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.